Collegium Pharmaceutical, Inc.
US ˙ NasdaqGS ˙ US19459J1043

SecurityCOLL / Collegium Pharmaceutical, Inc.
InstitutionQuest Partners LLC
Latest Disclosed Ownership31,967 shares
Latest Disclosed Value $ 1,480,072
Quest Partners LLC reports 27.85% increase in ownership of COLL / Collegium Pharmaceutical, Inc.

On February 9, 2026 - Quest Partners LLC filed a 13F-HR form disclosing ownership of 31,967 shares of Collegium Pharmaceutical, Inc. (US:COLL) valued at $1,480,072 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 3, 2025 disclosing 25,003 shares of Collegium Pharmaceutical, Inc.. This represents a change in shares of 27.85% during the quarter. The current value of the position is $992,895 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-09 2025-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 31,967 6,964 27.85 1,480 69.34 0.0828
2025-11-03 2025-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 25,003 15,769 170.77 875 220.15 0.0572
2025-07-31 2025-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 9,234 2,516 37.45 273 36.50 0.0268
2025-05-14 2025-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 6,718 -6,062 -47.43 201 -45.36 0.0218
2025-02-07 2024-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 12,780 374 3.01 366 -23.59 0.0486
2024-11-07 2024-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 12,406 -6,421 -34.11 479 -20.96 0.0427
2024-08-06 2024-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 18,827 12,244 185.99 606 137.65 0.0823
2024-05-09 2024-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 6,583 6,583 256 0.0444
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.